PDF herunterladen
Synlett 2015; 26(08): 1081-1084
DOI: 10.1055/s-0034-1380410
letter
© Georg Thieme Verlag Stuttgart · New York

Copper-Powder-Catalyzed Synthesis of Pyrimidines from β-Bromo α,β-Unsaturated Ketones and Amidine Hydrochlorides

Yang Jiao
Department of Applied Chemistry, Kyungpook National University, Daegu 702-701, Republic of Korea   eMail: cscho@knu.ac.kr
,
Son Long Ho
Department of Applied Chemistry, Kyungpook National University, Daegu 702-701, Republic of Korea   eMail: cscho@knu.ac.kr
,
Chan Sik Cho*
Department of Applied Chemistry, Kyungpook National University, Daegu 702-701, Republic of Korea   eMail: cscho@knu.ac.kr
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 14. Dezember 2014

Accepted after revision: 29. Januar 2015

Publikationsdatum:
20. Februar 2015 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik


Abstract

β-Bromo α,β-unsaturated ketones are coupled and cyclized with amidine hydrochlorides in the presence of a catalytic amount of copper powder along with a base to give the corresponding pyrimidines in good yields.

Key words

copper - coupling - cyclization - heterocycles - hetero­geneous catalysis
 

  • References and Notes

  • 1 Xie F, Zhao H, Zhao L, Lou L, Hu Y. Bioorg. Med. Chem. Lett. 2009; 19: 275
    CrossrefSuche in Google Scholar
  • 2 Joffe AM, Farley JD, Linden D, Goldsand G. Am J. Med. 1989; 87: 332
    CrossrefSuche in Google Scholar
  • 3 Xie F, Li S, Bai D, Lou L, Hu Y. J. Comb. Chem. 2007; 9: 12
    CrossrefSuche in Google Scholar
  • 4 Wang S, Wood G, Meades C, Griffiths G, Midgley C, McNae I, McInnes C, Anderson S, Jackson W, Mezna M, Yuill R, Walkinshaw M, Fisher PM. Bioorg. Med. Chem. Lett. 2004; 14: 4237
    CrossrefSuche in Google Scholar
  • 5 Atwal KS, O’Neil SV, Ahmad S, Doweyko L, Kirby M, Dorso CR, Chandrasena G, Chen B.-C, Zhao R, Zahler R. Bioorg. Med. Chem. Lett. 2006; 16: 4796
    CrossrefSuche in Google Scholar
  • 6 Lagoja IM. Chemistry & Biodiversity 2005; 2: 1
    CrossrefSuche in Google Scholar
  • 7 Undheim K, Benneche T In Comprehensive Heterocyclic Chemistry II . Vol. 6. Katritzky AR, Rees CW, Scriven EF. V. Pergamon Press; Oxford: 1996: 93
    CrossrefSuche in Google Scholar
  • 8 Truong VL, Morrow M. Tetrahedron Lett. 2010; 51: 758
    CrossrefSuche in Google Scholar
  • 9 Huang C, Fu Y, Fu H, Jiang Y, Zhao Y. Chem. Commun. 2008; 6333
  • 10 Gogoi J, Gogoi P, Benbaruah P, Boruah RC. Tetrahedron Lett. 2013; 54: 7136
    CrossrefSuche in Google Scholar
  • 14 Cho CS, Kim HB. Catal. Lett. 2010; 140: 116
    CrossrefSuche in Google Scholar
  • 15 Lee HK, Cho CS. Appl. Organomet. Chem. 2012; 26: 570
    CrossrefSuche in Google Scholar
  • 16 Yan S, Tang Y, Yu F, Lin J. Helv. Chim. Acta 2011; 94: 487
    CrossrefSuche in Google Scholar
  • 17 Kappe CO, Dallinger D, Murphree SS. Practical Microwave Synthesis for Organic Chemists . Wiley-VCH; Weinheim: 2009
    CrossrefSuche in Google Scholar
  • 18 Performing the reaction on a larger scale (6 times) resulted in a slightly decreased yield of 3a (71%).
  • 20 Luo Y, Herndon JW. Organometallics 2005; 24: 3099
    CrossrefSuche in Google Scholar
  • 21 Pyrimidines 3 – General Procedure To a 5 mL screw-capped vial was added β-bromo α,β-unsaturated ketone 1 (0.5 mmol) and amidine hydrochloride 2 (0.75 mmol), together with copper powder (Shinyo Pure Chemicals Co., 0.05 mmol), K3PO4 (1.5 mmol), and DMF (3 mL). The reaction mixture was stirred at 110 °C for 24 h. The mixture was then cooled to r.t. and filtered through a short column of silica gel (EtOAc) to remove inorganic salts. Removal of the solvent left a crude mixture, which was separated by TLC [silica gel 60 GF254 (Merck), EtOAc–hexane] to give desired products. Except for known 3e 23 and 3l,24 all new products were characterized spectroscopically as shown below. 4-Pentyl-2-phenyl-5,6,7,8-tetrahydroquinazoline (3a) Oil; yield 107 mg (76%). 1H NMR (400 MHz, CDCl3): δ = 0.93 (t, J = 7.1 Hz, 3 H), 1.34–1.45 (m, 4 H), 1.76–1.91 (m, 6 H), 2.69–2.74 (m, 4 H), 2.90–2.93 (m, 2 H), 7.39–7.47 (m, 3 H), 8.38–8.41 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 14.28, 22.51, 22.80, 22.86, 24.71, 27.51, 32.06, 32.91, 34.34, 128.08, 128.54, 129.89, 138.77, 161.19, 165.16, 168.71. HRMS (EI): m/z [M+] calcd for C19H24N2: 280.1939; found: 280.1941. 2-Methyl-4-pentyl-5,6,7,8-tetrahydroquinazoline (3b) Oil; yield 75 mg (69%). 1H NMR (400 MHz, CDCl3): δ = 0.89–0.92 (m, 3 H), 1.33–1.41 (m, 4 H), 1.61–1.68 (m, 2 H), 1.80–1.88 (m, 4 H), 2.60–2.68 (m, 4 H), 2.62 (s, 3 H), 2.80–2.83 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 14.14, 22.37, 22.67, 22.75, 24.41, 25.81, 28.21, 32.14, 32.53, 34.58, 124.23, 164.08, 164.96, 168.75. HRMS (EI): m/z [M+] calcd for C14H22N2: 218.1783; found: 218.1782. 4-Isopropyl-2-phenyl-5,6,7,8-tetrahydroquinazoline (3c) Solid; yield 86 mg (68%); mp 82–83 °C. 1H NMR (400 MHz, CDCl3): δ = 1.30 (d, J = 6.5 Hz, 6 H), 1.83–1.89 (m, 4 H), 2.72–2.74 (m, 2 H), 2.90–2.92 (m, 2 H), 3.19 (sept, J = 6.5 Hz, 1 H), 7.38–7.46 (m, 3 H), 8.44–8.46 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 21.32, 22.42, 22.90, 24.32, 30.71, 33.02, 124.47, 128.07, 128.44, 129.86, 138.88, 161.13, 165.27, 172.71. HRMS (EI): m/z [M+] calcd for C17H20N2: 252.1626; found: 252.1624. 4-Isopropyl-2-methyl-5,6,7,8-tetrahydroquinazoline (3d) Oil; yield 53 mg (56%). 1H NMR (400 MHz, CDCl3): δ = 1.22 (d, J = 6.5 Hz, 6 H), 1.82–1.85 (m, 4 H), 2.62 (s, 3 H), 2.67–2.69 (m, 2 H), 2.80–2.82 (m, 2 H), 3.14 (quint, J = 6.5 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 21.21, 22.38, 22.92, 24.17, 26.02, 30.43, 32.75, 123.23, 164.39, 164.83, 172.89. HRMS (EI): m/z [M+] calcd for C12H18N2: 190.1470; found: 190.1467. 2-Methyl-4-phenyl-5,6,7,8-tetrahydroquinazoline (3f) Oil; yield 53 mg (47%). 1H NMR (400 MHz, CDCl3): δ = 1.71–1.76 (m, 2 H), 1.89–1.94 (m, 2 H), 2.67–2.69 (m, 2 H), 2.71 (s, 3 H), 2.91–2.94 (m, 2 H), 7.40–7.46 (m, 3 H), 7.50–7.52 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 22.51, 22.93, 25.91, 26.66, 32.58, 124.43, 128.43, 128.75, 129.00, 138.53, 164.57, 165.48, 166.46. HRMS (EI): m/z [M+] calcd for C15H16N2: 224.1313; found: 224.1311. 2,6-Dimethyl-4-pentyl-5,6,7,8-tetrahydroquinazoline (3g) Oil; yield 66 mg (57%). 1H NMR (400 MHz, CDCl3): δ = 0.91 (t, J = 7.1 Hz, 3 H), 1.12 (d, J = 6.6 Hz, 3 H), 1.31–1.50 (m, 5 H), 1.61–1.69 (m, 2 H), 1.82–1.97 (m, 2 H), 2.17–2.25 (m, 1 H), 2.61–2.66 (m, 2 H), 2.62 (s, 3 H), 2.76–2.89 (m, 3 H). 13C NMR (100 MHz, CDCl3): δ = 14.11, 21.86, 22.64, 25.76, 28.18, 28.97, 30.42, 32.09, 32.22, 32.88, 34.55, 123.80, 164.07, 164.69, 168.64. HRMS (EI): m/z [M+] calcd for C15H24N2: 232.1939; found: 232.1941. 2-Methyl-4-pentyl-6,7-dihydro-5H-cyclopenta[d]pyrimidine (3h) Oil; yield 72 mg (70%). 1H NMR (400 MHz, CDCl3): δ = 0.90 (t, J = 7.0 Hz, 3 H), 1.33–1.37 (m, 4 H), 1.66–1.69 (m, 2 H), 2.08–2.14 (m, 2 H), 2.64 (t, J = 8.0 Hz, 2 H), 2.67 (s, 3 H), 2.89 (t, J = 7.5 Hz, 2 H), 2.96 (t, J = 8.0 Hz, 2 H). 13C NMR (100 MHz, CDCl3): δ = 14.14, 22.12, 22.67, 25.91, 28.17, 28.26, 31.96, 34.31, 35.86, 129.26, 165.52, 166.07, 174.25. Anal. Calcd for C13H20N2: C, 76.42; H, 9.87; N, 13.71. Found: C, 76.28; H, 9.80; N, 13.75. 2-Methyl-4-pentyl-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidine (3i) Oil; yield 78 mg (67%). 1H NMR (400 MHz, CDCl3): δ = 0.90 (t, J = 7.0 Hz, 3 H), 1.31–1.42 (m, 4 H), 1.57–1.71 (m, 6 H), 1.84–1.90 (m, 2 H), 2.62 (s, 3 H), 2.72–2.79 (m, 4 H), 2.92–2.95 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 14.12, 22.65, 25.79, 26.00, 27.43, 27.77, 29.42, 32.05, 32.34, 35.72, 38.78, 129.66, 164.08, 166.87, 171.16. HRMS (EI): m/z [M+] calcd for C15H24N2: 232.1939; found: 232.1940. 2-Methyl-4-pentyl-5,6,7,8,9,10-hexahydrocycloocta[d]pyrimidine (3j) Oil; yield 74 mg (60%). 1H NMR (400 MHz, CDCl3): δ = 0.91 (t, J = 7.1 Hz, 3 H), 1.33–1.47 (m, 8 H), 1.63–1.73 (m, 4 H), 1.76–1.82 (m, 2 H), 2.64 (s, 3 H), 2.68–2.72 (m, 2 H), 2.78–2.81 (m, 2 H), 2.86–2.89 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 14.18, 22.73, 25.53, 25.91, 25.94, 26.47, 29.54, 30.39, 30.50, 32.23, 34.90, 35.10, 127.16, 164.74, 167.83, 169.37. HRMS (EI): m/z [M+] calcd for C16H26N2: 246.2096; found: 246.2095. 2-Methyl-4-pentyl-5,6,7,8,9,10,11,12,13,14-decahydrocyclododeca[d]pyrimidine (3k) Oil; yield 91 mg (60%). 1H NMR (400 MHz, CDCl3): δ = 0.91 (m, J = 7.1 Hz, 3 H), 1.31–1.72 (m, 20 H), 1.81–1.88 (m, 2 H), 2.62 (s, 3 H), 2.66–2.76 (m, 6 H). 13C NMR (100 MHz, CDCl3): δ = 14.18, 22.48, 22.75, 23.12, 25.21, 25.88, 26.04, 26.57, 26.90, 27.42, 27.83, 28.57, 29.62, 32.23, 32.26, 35.01, 127.49, 164.22, 168.80, 169.20. HRMS (EI): m/z [M+] calcd for C20H34N2: 302.2722; found: 302.2719. 2-Methyl-4-pentyl-5,6-diphenylpyrimidine (3m) Solid; yield 55 mg (35%); mp 62–64 °C. 1H NMR (400 MHz, CDCl3): δ = 0.70–0.74 (m, 3 H), 1.09–1.14 (m, 4 H), 1.49–1.57 (m, 2 H), 2.51–2.55 (m, 2 H), 2.74 (s, 3 H), 7.00–7.02 (m, 2 H), 7.08–7.14 (m, 3 H), 7.19–7.24 (m, 5 H). 13C NMR (100 MHz, CDCl3): δ = 14.07, 22.45, 26.36, 29.25, 31.93, 35.71, 127.62, 127.97, 128.53, 128.63, 129.37, 129.78, 130.48, 136.74, 138.76, 164.17, 166.47, 169.65. HRMS (EI): m/z [M+] calcd for C22H24N2: 316.1939; found: 316.1938.
  • 22 A reviewer suggested that the present reaction might be tolerant of several functional groups such as hydroxy, amino, and ester. However, it is difficult to examine such functional-group compatibility at present since the synthetic course of the starting 1 uses Grignard reagents as a step. Thus, further application of this method to the synthesis of such functional-group-containing pyrimidines needs more elaborate plans.
  • 23 Herrera A, Martínez-Álvarez R, Chioua M, Sánchez Á, Molero D, Chioua R. Magn. Reson. Chem. 2002; 40: 293
    CrossrefSuche in Google Scholar
  • 24 Herrera A, Martínez-Álvarez R, Chioua M, Chioua R, Sánchez Á. Tetrahedron 2002; 58: 10053
    CrossrefSuche in Google Scholar